XML 70 R44.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT INFORMATION (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of operating segments [abstract]  
Schedule of Revenue by Geographical Area Based on Location of Assets
Revenue
 
Americas
   
Rest of World Ireland
   
Eliminations
   
Total
 
Year ended December 31, 2024
 
US$‘000
   
US$‘000
   
US$’000
   
US$‘000
 
Revenue from external customers
   
41,792
     
19,763
     
-
     
61,555
 
Inter-segment revenue
   
19,815
     
702
     
(20,517
)
   
-
 
                                 
Total revenue
   
61,607
     
20,465
     
(20,517
)
   
61,555
 
 
Revenue
 
Americas
   
Rest of World Ireland
   
Eliminations
   
Total
 
Year ended December 31, 2023
 
US$‘000
   
US$‘000
   
US$’000
   
US$‘000
 
Revenue from external customers
   
44,984
     
11,848
     
-
     
56,832
 
Inter-segment revenue
   
21,867
     
872
     
(22,739
)
   
-
 
                                 
Total revenue
   
66,851
     
12,720
     
(22,739
)
   
56,832
 
 
Revenue
 
Americas
   
Rest of World Ireland
   
Eliminations
   
Total
 
Year ended December 31, 2022
 
US$‘000
   
US$‘000
   
US$‘000
   
US$‘000
 
Revenue from external customers
   
50,508
     
12,013
     
-
     
62,521
 
Inter-segment revenue
   
26,110
     
828
     
(26,938
)
   
-
 
 
                               
Total revenue
   
76,618
     
12,841
     
(26,938
)
   
62,521
 
Schedule of Revenue by Customers' Geographical Area
Revenue
 
December 31, 2024
US$‘000
   
December 31, 2023
US$‘000
   
December 31, 2022
US$‘000
 
Americas
   
29,917
     
32,282
     
35,557
 
Asia / Africa
   
24,775
     
18,909
     
20,401
 
Europe (including Ireland) *
   
6,863
     
5,641
     
6,563
 
 
                       
 
   
61,555
     
56,832
     
62,521
 
 
  *
Revenue from customers in Ireland is not disclosed separately due to the immateriality of these revenues.
Schedule of Revenue by Major Product Group
Revenue
 
December 31, 2024
US$‘000
   
December 31, 2023
US$‘000
   
December 31, 2022
US$‘000
 
Clinical laboratory goods
   
39,372
     
42,288
     
46,036
 
Clinical laboratory services
   
4,750
     
5,453
     
7,272
 
Point-of-care
   
17,433
     
9,091
     
9,213
 
 
                       
 
   
61,555
     
56,832
     
62,521
 
Schedule of Amount Relating From Revenue
Revenue
 
December 31, 2024
US$‘000
   
December 31, 2023
US$‘000
   
December 31, 2022
US$‘000
 
Revenue from contracts with customers
   
61,555
     
56,832
     
62,521
 
 
                       
 
   
61,555
     
56,832
     
62,521
 
Schedule of Revenue Derives From Transfer of Goods and Services
Timing of revenue recognition
 
Americas
   
Rest of World Ireland
   
Total
 
Year ended December 31, 2024
 
US$‘000
   
US$‘000
   
US$‘000
 
At a point in time
   
41,536
     
19,763
     
61,299
 
Over time
   
256
     
-
     
256
 
 
                       
Total
   
41,792
     
19,763
     
61,555
 
 
Timing of revenue recognition
 
Americas
   
Rest of World
Ireland
   
Total
 
Year ended December 31, 2023
 
US$‘000
   
US$‘000
   
US$‘000
 
At a point in time
   
44,692
     
11,848
     
56,540
 
Over time
   
292
     
-
     
292
 
 
                       
Total
   
44,984
     
11,848
     
56,832
 
 
Timing of revenue recognition
 
Americas
   
Rest of World
Ireland
   
Total
 
Year ended December 31, 2022
 
US$‘000
   
US$‘000
   
US$‘000
 
At a point in time
   
50,174
     
12,013
     
62,187
 
Over time
   
334
     
-
     
334
 
 
                       
Total
   
50,508
     
12,013
     
62,521
 
Timing of revenue recognition
 
Americas
   
Asia / Africa
   
Europe
   
Total
 
Year ended December 31, 2024
 
US$‘000
   
US$‘000
   
US$‘000
   
US$‘000
 
At a point in time
   
29,661
     
24,775
     
6,863
     
61,299
 
Over time
   
256
     
-
     
-
     
256
 
 
                               
Total
   
29,917
     
24,775
     
6,863
     
61,555
 
 
Timing of revenue recognition
 
Americas
   
Asia / Africa
   
Europe
   
Total
 
Year ended December 31, 2023
 
US$‘000
   
US$‘000
   
US$‘000
   
US$‘000
 
At a point in time
   
31,990
     
18,909
     
5,641
     
56,540
 
Over time
   
292
     
-
     
-
     
292
 
 
                               
Total
   
32,282
     
18,909
     
5,641
     
56,832
 
 
Timing of revenue recognition
 
Americas
   
Asia / Africa
   
Europe
   
Total
 
Year ended December 31, 2022
 
US$‘000
   
US$‘000
   
US$‘000
   
US$‘000
 
At a point in time
   
35,223
     
20,401
     
6,563
     
62,187
 
Over time
   
334
     
-
     
-
     
334
 
 
                               
Total
   
35,557
     
20,401
     
6,563
     
62,521
 
Schedule of Segment Results by Geographical Area
 
       
Rest of World
       
 
 
Americas
   
Ireland
   
Other
   
Total
 
Year ended December 31, 2024
 
US$‘000
   
US$‘000
   
US$‘000
   
US$‘000
 
Result before restructuring costs, impairment and unallocated expenses
   
(2,503
)
   
(9,386
)
   
(315
)
   
(12,204
)
Restructuring costs
   
(2,025
)
   
(2,156
)
           
(4,181
)
Impairment charges
   
(612
)
   
(796
)
   
-
     
(1,408
)
 
                               
Result after impairment
   
(5,140
)
   
(12,338
)
   
(315
)
   
(17,793
)
Unallocated expenses *
                           
(3,372
)
 
                               
Operating loss
                           
(21,165
)
Net financing expense (Note 6)
                           
(9,565
)
 
                               
Loss before tax
                           
(30,730
)
Income tax credit (Note 7)
                           
(486
)
 
                               
Loss for the year on continuing operations
                           
(31,216
)
Loss for the year on discontinued operations (Note 8)
                           
(573
)
 
                               
Loss for the year
                           
(31,789
)
 
 
       
Rest of World
       
 
 
Americas
   
Ireland
   
Other
   
Total
 
Year ended December 31, 2023
 
US$‘000
   
US$‘000
   
US$‘000
   
US$‘000
 
Result before restructuring costs, impairment and unallocated expenses
   
(4,365
)
   
(7,886
)
   
(104
)
   
(12,355
)
Impairment charges
   
(11,105
)
   
-
     
-
     
(11,105
)
 
                               
Result after impairment
   
(15,470
)
   
(7,886
)
   
(104
)
   
(23,460
)
Unallocated expenses *
                           
(3,585
)
 
                               
Operating loss
                           
(27,045
)
Net financing expense (Note 6)
                           
(9,882
)
 
                               
Loss before tax
                           
(36,927
)
Income tax charge (Note 7)
                           
59
 
 
                               
Loss for the year on continuing operations
                           
(36,868
)
Profit for the year on discontinued operations (Note 8)
                           
12,850
 
 
                               
Loss for the year
                           
(24,018
)
 
       
Rest of World
       
 
 
Americas
   
Ireland
   
Other
   
Total
 
Year ended December 31, 2022
 
US$‘000
   
US$‘000
   
US$‘000
   
US$‘000
 
Result before restructuring costs, impairment and unallocated expenses
   
(5,892
)
   
(5,112
)
   
(33
)
   
(11,037
)
Impairment
   
(2,331
)
   
(3,508
)
   
-
     
(5,839
)
 
                               
Result after impairment
   
(8,223
)
   
(8,620
)
   
(33
)
   
(16,876
)
Unallocated expenses *
                           
(2,473
)
 
                               
Operating loss
                           
(19,349
)
Net financing expense (Note 6)
                           
(24,431
)
 
                               
Loss before tax
                           
(43,780
)
Income tax credit (Note 7)
                           
194
 
 
                               
Loss for the year on continuing operations
                           
(43,586
)
Profit for the year on discontinued operations (Note 8)
                           
2,577
 
 
                               
Loss for the year
                           
(41,009
)
 
*
Unallocated expenses represent head office general and administration costs of the Group, which cannot be allocated to the results of any specific geographical area.
Schedule of Segment Assets and Segment Liabilities by Geographical Area
 
       
Rest of World
       
 
 
Americas
   
Ireland
   
Other
   
Total
 
As at December 31, 2024
 
US$‘000
   
US$‘000
   
US$‘000
   
US$‘000
 
Assets and liabilities
                       
Segment assets
   
32,798
     
61,254
     
-
     
94,052
 
Unallocated assets:
                               
Income tax assets (current and deferred)
                           
4,071
 
Cash and cash equivalents and short-term investments
                           
5,167
 
                                 
Total assets as reported in the Group balance sheet
                           
103,290
 
 
                               
Segment liabilities
   
84,863
     
48,621
     
62
     
133,546
 
Unallocated liabilities:
                               
Income tax liabilities (current and deferred)
                           
4,925
 
 
                               
Total liabilities as reported in the Group balance sheet
                           
138,471
 
 
 
       
Rest of World
       
 
 
Americas
   
Ireland
   
Other
   
Total
 
As at December 31, 2023
 
US$‘000
   
US$‘000
   
US$‘000
   
US$‘000
 
Assets and liabilities
                       
Segment assets
   
26,230
     
26,023
     
-
     
52,253
 
Unallocated assets:
                               
Income tax assets (current and deferred)
                           
3,491
 
Cash and cash equivalents and short-term investments
                           
3,691
 
                                 
Total assets as reported in the Group balance sheet
                           
59,435
 
 
                               
Segment liabilities
   
49,398
     
31,387
     
20
     
80,805
 
Unallocated liabilities:
                               
Income tax liabilities (current and deferred)
                           
2,579
 
 
                               
Total liabilities as reported in the Group balance sheet
                           
83,384
 
Schedule of Long-Lived Assets
 
 
December 31, 2024
US$‘000
   
December 31, 2023
US$‘000
 
Rest of World – Ireland
   
43,504
     
12,448
 
Americas
   
14,943
     
5,793
 
 
               
 
   
58,447
     
18,241
Schedule of Depreciation and Amortisation by Geographical Area
 
 
December 31, 2024
US$‘000
   
December 31, 2023
US$‘000
   
December 31, 2022
US$‘000
 
Depreciation:
                 
Rest of World – Ireland
   
160
     
162
     
123
 
Americas
   
515
     
668
     
1,282
 
 
                       
 
   
675
     
830
     
1,405
 
 
                       
Amortisation:
                       
Rest of World – Ireland
   
770
     
458
     
89
 
Americas
   
420
     
487
     
800
 
 
                       
 
   
1,190
     
945
     
889
 
Schedule Of Share Based Payment Expense By Geographical Area
 
 
December 31, 2024
US$‘000
   
December 31, 2023
US$‘000
   
December 31, 2022
US$‘000
 
Rest of World – Ireland
   
843
     
1,650
     
632
 
Americas
   
473
     
419
     
1,123
 
 
                       
 
   
1,316
     
2,069
     
1,755
 
Schedule of Taxation Expense by Geographical Area
 
 
December 31, 2024
US$‘000
   
December 31, 2023
US$‘000
   
December 31, 2022
US$‘000
 
Rest of World – Ireland
   
(5
)    
(385
)
   
286
 
Rest of World – Other
   
9
     
(235
)
   
(4
)
Americas
   
(490
)
   
679
     
(88
)
 
                       
 
   
(486
)
   
59
     
194
Schedule of Capital Expenditure by Geographical Area
 
 
December 31 2024
US$‘000
   
December 31, 2023
US$‘000
 
Rest of World – Ireland
   
37,929
     
251
 
Americas
   
2,753
     
2,547
 
 
               
 
   
40,682
     
2,798